
Hypercalcemia
Hypercalcemia
Hypercalcemia is a condition characterized by elevated calcium levels in the blood, often caused by primary hyperparathyroidism or vitamin D toxicity. Bisphosphonates are considered the gold standard for treating hypercalcemia, helping to reduce calcium levels and alleviate associated symptoms.
Read our guide to: Hypercalcemia
Hypercalcemia
How Hypercalcemia Medications Work
Hypercalcemia, a condition characterized by elevated serum calcium levels, can be treated with various medications. The primary goal of these treatments is to reduce serum calcium levels and alleviate associated symptoms.
Treatment Options
- Bisphosphonates: These are the gold standard for treating hypercalcemia. Bisphosphonates work by inhibiting osteoclast-mediated bone resorption, thereby reducing the release of calcium into the bloodstream.
- Alternatives:
- Calcimimetics: These medications mimic the action of calcium on the parathyroid gland, reducing PTH secretion and subsequently lowering serum calcium levels.
- Denosumab: A monoclonal antibody that inhibits RANKL, a protein involved in bone resorption. This leads to reduced bone turnover and decreased serum calcium levels.
- Hormone Replacement Therapy (HRT): In some cases, HRT may be used to treat hypercalcemia associated with vitamin D toxicity or primary hyperparathyroidism.
Key Considerations
When selecting a medication for treating hypercalcemia, it is essential to consider the underlying cause of the condition and potential interactions with other medications. Regular monitoring of serum calcium levels and PTH levels is crucial to ensure effective treatment and prevent complications.